Edgewise Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	33.21	61.15	41.67	86.1	21.99	15.57
Short-Term Investments	466.35	468.96	428.5	232.3	329.95	265.22
Cash & Short-Term Investments	499.56	530.11	470.17	318.39	351.95	280.79
Cash Growth	14.48%	12.75%	47.67%	-9.53%	25.34%	117.51%
Other Current Assets	10.23	13.28	5.31	8.6	5.05	2.98
Total Current Assets	509.79	543.39	475.48	327	357	283.77
Net Property, Plant & Equipment	8.73	9.22	11.07	12.69	9.85	0.91
Other Long-Term Assets	-	-	0.26	0.35	0.25	0.55
Total Assets	518.52	552.6	486.82	340.04	367.1	285.23
Accounts Payable	7.29	6.01	5.58	4.03	6.11	3.84
Accrued Expenses	14.23	20.35	17.29	11.77	9.87	6.68
Current Portion of Leases	1.02	1.01	1	0.98	0.61	-
Total Current Liabilities	22.54	27.37	23.86	16.77	16.59	10.52
Long-Term Leases	2.78	2.98	3.74	4.43	3.8	-
Other Long-Term Liabilities	-	-	-	-	-	0.33
Total Long-Term Liabilities	2.78	2.98	3.74	4.43	3.8	0.33
Total Liabilities	25.32	30.35	27.6	21.21	20.39	10.85
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-in Capital	1,089	1,068	837.36	563.49	492.67	351.85
Accumulated Other Comprehensive Income	-0.25	0.68	0.42	0.1	-1.36	-0.51
Retained Earnings	-595.38	-546.37	-378.58	-244.76	-144.6	-76.96
Total Common Shareholders' Equity	493.2	522.26	459.22	318.83	346.72	274.38
Shareholders' Equity	493.2	522.26	459.22	318.83	346.72	274.38
Total Liabilities & Equity	518.52	552.6	486.82	340.04	367.1	285.23
Total Debt	3.79	3.99	4.74	5.41	4.41	0
Net Cash (Debt)	495.77	526.12	465.43	312.98	347.54	280.79
Net Cash Growth	-5.77%	13.04%	48.71%	-9.94%	23.77%	117.51%
Net Cash Per Share	4.68	5.11	5.04	4.91	6.49	7.48
Book Value	493.2	522.26	459.22	318.83	346.72	274.38
Book Value Per Share	4.66	5.07	4.97	5.00	6.47	7.31
Tangible Book Value	493.2	522.26	459.22	318.83	346.72	274.38
Tangible Book Value Per Share	4.66	5.07	4.97	5.00	6.47	7.31

SEC Filings: 10-K · 10-Q